Increased expression of angiogenic genes in the brains of mouse meg3-null embryos
- PMID: 20392836
- PMCID: PMC2875815
- DOI: 10.1210/en.2009-1151
Increased expression of angiogenic genes in the brains of mouse meg3-null embryos
Abstract
Maternally expressed gene 3 (MEG3) is a noncoding RNA highly expressed in the normal human brain and pituitary. Expression of MEG3 is lost in gonadotroph-derived clinically nonfunctioning pituitary adenomas. Meg3 knockout mice were generated to identify targets and potential functions of this gene in embryonic development and tumorigenesis. Gene expression profiles were compared in the brains of Meg3-null embryos and wild-type littermate controls using microarray analysis. Microarray data were analyzed with GeneSifter, which uses Kyoto Encyclopedia of Genes and Genomes pathways and Gene Ontology classifications to identify signaling cascades and functional categories of interest within the dataset. Differences were found in signaling pathways and ontologies related to angiogenesis between wild-type and knockout embryos. Quantitative RT-PCR and immunohistological staining showed increased expression of some Vascular Endothelial Growth Factor pathway genes and increased cortical microvessel density in the Meg3-null embryos. In conclusion, Meg3 may play an important role in control of vascularization in the brain and may function as a tumor suppressor in part by inhibiting angiogenesis.
Figures
Similar articles
-
Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas.J Clin Endocrinol Metab. 2008 Oct;93(10):4119-25. doi: 10.1210/jc.2007-2633. Epub 2008 Jul 15. J Clin Endocrinol Metab. 2008. PMID: 18628527 Free PMC article.
-
Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions.Endocrinology. 2010 Mar;151(3):939-47. doi: 10.1210/en.2009-0657. Epub 2009 Dec 23. Endocrinology. 2010. PMID: 20032057 Free PMC article.
-
Molecular characterization and expression of maternally expressed gene 3 (Meg3/Gtl2) RNA in the mouse inner ear.J Neurosci Res. 2006 Feb 1;83(2):181-90. doi: 10.1002/jnr.20721. J Neurosci Res. 2006. PMID: 16342203
-
Knockdown of long noncoding RNA MEG3 impairs VEGF-stimulated endothelial sprouting angiogenesis via modulating VEGFR2 expression in human umbilical vein endothelial cells.Gene. 2018 Apr 5;649:32-39. doi: 10.1016/j.gene.2018.01.072. Epub 2018 Jan 31. Gene. 2018. PMID: 29391273
-
MEG3 noncoding RNA: a tumor suppressor.J Mol Endocrinol. 2012 Apr 2;48(3):R45-53. doi: 10.1530/JME-12-0008. Print 2012 Jun. J Mol Endocrinol. 2012. PMID: 22393162 Free PMC article. Review.
Cited by
-
Advances in Engineered Nanoparticles for the Treatment of Ischemic Stroke by Enhancing Angiogenesis.Int J Nanomedicine. 2024 May 17;19:4377-4409. doi: 10.2147/IJN.S463333. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38774029 Free PMC article. Review.
-
Control of endothelial cell function and arteriogenesis by MEG3:EZH2 epigenetic regulation of integrin expression.Mol Ther Nucleic Acids. 2024 Apr 6;35(2):102173. doi: 10.1016/j.omtn.2024.102173. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38617973 Free PMC article.
-
Ostarine blunts the effect of endurance training on submaximal endurance in rats.Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6523-6532. doi: 10.1007/s00210-024-03030-w. Epub 2024 Mar 7. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38451281 Free PMC article.
-
Epigenetic Regulation of Angiogenesis in Peripheral Artery Disease.Methodist Debakey Cardiovasc J. 2023 Nov 16;19(5):47-57. doi: 10.14797/mdcvj.1294. eCollection 2023. Methodist Debakey Cardiovasc J. 2023. PMID: 38028966 Free PMC article. Review.
-
Mice With RIP-Cre-mediated Deletion of the Long Noncoding RNA Meg3 Show Normal Pancreatic Islets and Enlarged Pituitary.J Endocr Soc. 2022 Sep 13;6(11):bvac141. doi: 10.1210/jendso/bvac141. eCollection 2022 Oct 11. J Endocr Soc. 2022. PMID: 37283960 Free PMC article.
References
-
- Asa SL, Ezzat S 2002 The pathogenesis of pituitary tumours. Nat Rev Cancer 2:836–849 - PubMed
-
- Dekkers OM, Hammer S, de Keizer RJ, Roelfsema F, Schutte PJ, Smit JW, Romijn JA, Pereira AM 2007 The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol 156:217–224 - PubMed
-
- Colao A, Di Somma C, Pivonello R, Faggiano A, Lombardi G, Savastano S 2008 Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer 15:905–915 - PubMed
-
- Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, Klibanski A 2003 A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 88: 5119–5126 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases